4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-25-003957
Head of Pharm Ops and Tech gave up 1,223 shares (to pay taxes)
- Head of Pharm Ops and Tech acquired 4,042 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Murphy Nicole · Head of Pharm Ops and Tech
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-07 | Exercise or conversion : show line 1 in the form | +2,102 | 11,736.37 | D | ||
| 2025-02-07 | Shares withheld for taxes : show line 2 in the form | −620 | $141.35 | $87,637 | 11,116.37 | D |
| 2025-02-07 | Exercise or conversion : show line 3 in the form | +1,940 | 13,056.37 | D | ||
| 2025-02-07 | Shares withheld for taxes : show line 4 in the form | −603 | $141.35 | $85,234 | 12,453.37 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-06 | Grant or award : show line 5 in the form Restricted Stock Unit | +14,050 | 14,050 | D |
| 2025-02-07 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −2,102 | 2,102 | D |
| 2025-02-07 | Exercise or conversion : show line 7 in the form Restricted Stock Unit | −1,940 | 3,880 | D |
Loading xslF345X05/form4.xml…